Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MRPS23 is a novel prognostic biomarker and promotes glioma progression.

Aging - 31 Jan 2024

Wang Qiang, Chen Guiqing, Liu Liang, Peng Xiaoying, Yang Xian, Yang Ling, Li Chunhong

Abstract excerpt

Mitochondrial ribosomal protein S23 (MRPS23), a component of the ribosome small subunit, has been reported to be overexpressed in various cancers and has been predicted to be involved in increased cell proliferation. It has been confirmed that MRPS23 was involved in the regulation of breast cancer and hepatocellular carcinoma cell proliferation. However, little is known about the function of MRPS23 in glioma. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 38301044
DOI: 10.18632/aging.205493
PMCID: PMC10911364

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MRPS23 is a novel prognostic biomarker and promotes glioma progression.PMID 38301044Read ↗

Mitochondrial ribosomal proteins: potential targets for cancer prognosis and therapySemantic proximity Read ↗

A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidateSemantic proximity Read ↗

MRPS28 serves as a biomarker of diagnostic, prognostic, and immune modulation in pan-cancer and promotes breast cancer malignant phenotypes.Semantic proximity Read ↗

Pan-cancer analysis of the oncogenic effects of ribosomal protein L13 (MRPL13) and validation in hepatocellular carcinomaSemantic proximity Read ↗

MRPS16 facilitates tumor progression via the PI3K/AKT/Snail signaling axisSemantic proximity Read ↗

A multidimensional analysis of MRPL17 protein in human tumorsSemantic proximity Read ↗

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinomaSemantic proximity Read ↗

Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer.Semantic proximity Read ↗

UTP23 is a promising prognostic biomarker and is associated with immune infiltration in breast cancerSemantic proximity Read ↗

The role of the mitochondrial ribosomal protein family in detecting hepatocellular carcinoma and predicting prognosis, immune features, and drug sensitivitySemantic proximity Read ↗

Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancerSemantic proximity Read ↗

MicroRNA-424 inhibits cell migration, invasion and epithelial-mesenchymal transition in human glioma by targeting KIF23 and functions as a novel prognostic predictor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.